Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
A Pharmacokinetic-pharmacodynamic Model for the Mobilization of CD34 Hematopoietic Progenitor Cells by AMD3100Lack, N. A. ; Green, B. ; Dale, D. C. ; Calandra, G. B. ; Lee, H. ; MacFarland, R. T. ; Badel, K. ; Liles, W. C. ; Bridger, G.Clinical pharmacology and therapeutics, 2005-05, Vol.77 (5), p.427-436 [Periódico revisado por pares]New York, NY: Nature PublishingTexto completo disponível |
|
2 |
Material Type: Artigo
|
A prospective clinical trial evaluating the safety and efficacy of the combination of rituximab and plerixafor as a mobilization regimen for patients with lymphomaKaufman, Jonathan L. ; Flowers, Christopher R. ; Rados, Karen D. ; Calandra, Gary B. ; Vose, Julie M. ; Hewes, L. Becker ; Lonial, Sagar ; Langston, Amelia A. ; Khoury, H. Jean ; Lechowicz, Mary Jo ; Waller, Edmund K.Transfusion (Philadelphia, Pa.), 2013-01, Vol.53 (1), p.76-84 [Periódico revisado por pares]Malden, USA: Blackwell Publishing IncTexto completo disponível |
|
3 |
Material Type: Artigo
|
SR141716A, a potent and selective antagonist of the brain cannabinoid receptorRinaldi-Carmona, Murielle ; Barth, Francis ; Héaulme, Michel ; Shire, David ; Calandra, Bernard ; Congy, Christian ; Martinez, Serge ; Maruani, Jeanne ; Néliat, Gervais ; Caput, Daniel ; Ferrara, Pascual ; Soubrié, Philippe ; Brelière, Jean Claude ; Le Fur, GérardFEBS letters, 1994-08, Vol.350 (2), p.240-244 [Periódico revisado por pares]England: Elsevier B.VTexto completo disponível |
|
4 |
Material Type: Artigo
|
The Efficacy Results and Safety Profile of Imipenem/Cilastatin from the Clinical Research TrialsCalandra, G. B. ; Ricci, F. M. ; Wang, C. ; Brown, K. R.Journal of clinical pharmacology, 1988-02, Vol.28 (2), p.120-127 [Periódico revisado por pares]Oxford, UK: Blackwell Publishing LtdSem texto completo |
|
5 |
Material Type: Artigo
|
Evidence for idiotypic sharing between conventional and naturally activated B cellsSong, Charles H. ; Calandra, Gertrudis B. ; Miller, Alexander ; Sercarz, Eli E. ; Keller, Margaret A.European journal of immunology, 1991-09, Vol.21 (9), p.2005-2010 [Periódico revisado por pares]Weinheim: WILEY‐VCH Verlag GmbHSem texto completo |
|
6 |
Material Type: Artigo
|
Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expressionBouaboula, M ; Poinot-Chazel, C ; Marchand, J ; Canat, X ; Bourrié, B ; Rinaldi-Carmona, M ; Calandra, B ; Le Fur, G ; Casellas, PEuropean journal of biochemistry, 1996-05, Vol.237 (3), p.704-711 [Periódico revisado por pares]EnglandTexto completo disponível |
|
7 |
Material Type: Artigo
|
Preparation of Protoplasts of Group H Streptococci (Streptococcus sanguis)Calandra, G B ; Nugent, K M ; Cole, R MApplied Microbiology, 1975-01, Vol.29 (1), p.90-93 [Periódico revisado por pares]United States: American Society for MicrobiologyTexto completo disponível |
|
8 |
Material Type: Artigo
|
The pathogenesis of group a streptococcal cell wall‐induced polyarthritis in the rat comparative studies in arthritis resistant and susceptible inbred rat strainsWilder, Ronald L. ; Allen, Janice B. ; Wahl, Larry M. ; Calandra, Gary B. ; Wahl, Sharon M.Arthritis and rheumatism, 1983-12, Vol.26 (12), p.1442-1451New York: John Wiley & Sons, IncTexto completo disponível |
|
9 |
Material Type: Artigo
|
Sex hormonal effects on the severity of streptococcal cell wall‐induced polyarthritis in the ratAllen, Janice B. ; Blatter, Duane ; Calandra, Gary B. ; Wilder, Ronald L.Arthritis and rheumatism, 1983-04, Vol.26 (4), p.560-563New York: John Wiley & Sons, IncTexto completo disponível |
|
10 |
Material Type: Artigo
|
STRAIN and sex variation in the susceptibility to streptococcal CELL WALL–INDUCED POLYARTHRITIS IN THE RATWilder, Ronald L. ; Calandra, Gary B. ; Garvin, A. Julian ; Wright, Karen D. ; Hansen, Carl T.Arthritis and rheumatism, 1982-09, Vol.25 (9), p.1064-1072New York: John Wiley & Sons, IncTexto completo disponível |